title: Varying clinical features of Turkish Kawasaki disease patients.
abstract: Kawasaki disease (KD) is an acute, systemic and self-limited vasculitis that is complicated with the development of coronary artery (CA) aneurysms. We present the clinical features of Turkish KD patients from a tertiary referral center. When 33 KD patients were assessed, a number of features stood out as differing from the expected, for example, periungual peeling 7.5 +/- 7.5 days after fever onset--42.4% of patients had periungual peeling within 14 days after fever onset. CA involvement was detected at an average of 12.3 +/- 7.9 days after fever onset. Fifty percent of the patients had been diagnosed to have CA involvement within eight days after the onset of fever. The performance of criteria suggested by American Heart Association was satisfactory, with 19 of 29 patients (65.5%) having three or more of the required laboratory features (sensitivity 65.5%). We believe Turkish patients may present differences in the course of KD.
authors.affiliation: Division of 1Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
authors.forename: Bora
authors.initials: B
authors.lastname: Gülhan
authors.forename: Selman
authors.initials: S
authors.lastname: Kesici
authors.forename: Serdar
authors.initials: S
authors.lastname: Beken
authors.forename: Erman
authors.initials: E
authors.lastname: Cilsal
authors.forename: Gülsev
authors.initials: G
authors.lastname: Kale
authors.forename: Dursun
authors.initials: D
authors.lastname: Alehan
authors.forename: Ateş
authors.initials: A
authors.lastname: Kara
authors.forename: Seza
authors.initials: S
authors.lastname: Ozen
mesh_terms: D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D014421:Turkey / Q000453:epidemiology
chemical_list: D016756:Immunoglobulins, Intravenous